BioXcel Therapeutics, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold BTAI, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
8
Funds holding
$325529
Total value held
Buying
4 added/new · 3 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | State Street Corp | $123438 | 92118 | +28900 | +45.71% |
| 2 | Blackrock, Inc. | $112938 | 84282 | -114 | -0.14% |
| 3 | Northern Trust Corp | $48659 | 36313 | -2057 | -5.36% |
| 4 | Citigroup Inc | $19326 | 12079 | +11724 | +3302.54% |
| 5 | Morgan Stanley | $14188 | 10588 | +9124 | +623.22% |
| 6 | Wells Fargo & Company/Mn | $6920 | 4325 | -11991 | -73.49% |
| 7 | Amalgamated Financial Corp. | $59 | 2816 | — | NEW BUY |
| 8 | Us Bancorp \De\ | $1 | 1 | — | Held |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.